Glycosaminoglycans from food
Preclinical · 6 studies cited · 3 min · Updated 2026-08-15
In short: Chondroitin sulfate extracted from chicken bone soup measured 35.8 kDa against 37.2 for an enzymatically purified reference — it survives cooking essentially intact, and it was one of the two constituents that improved bone density in the only bone-broth animal study with a skeletal outcome. The catch is dose: a whole chicken carcass holds about 1.9 g of chondroitin in total, against trial doses of 800-1200 mg a day. Keratan and dermatan sulfate have never been measured in any stock by anyone.
Cartilage is not mostly collagen by function — it is collagen fibres holding a water-swollen gel of glycosaminoglycans, and it is the gel that resists compression. So the second question about any collagen-rich food is what glycosaminoglycans it delivers: chondroitin sulfate, hyaluronic acid, keratan sulfate, dermatan sulfate.
The answers range from "surprisingly good" to "nobody has ever looked."
Chondroitin sulfate survives cooking
This is the genuinely encouraging finding. Chondroitin was extracted from ordinary chicken leg bone soup and compared against chondroitin obtained enzymatically from the same bones. The soup-derived molecule averaged 35.81 kDa, the enzymatic reference 37.18 kDa, and infrared spectroscopy and HPLC found no significant structural difference.
That is a roughly 4 percent difference in molecular weight. Chondroitin comes through a simmer essentially intact, which is not obvious in advance — plenty of food polysaccharides do not.
It also does something. In the one bone-broth animal study with a skeletal endpoint, chicken-vegetable broth was fractionated by ion-exchange chromatography, and the fraction containing hyaluronan and chondroitin sulfate was the one that most inhibited osteoclast differentiation. Both the whole broth and that fraction raised bone mineral density and bone volume in ovariectomised rats. Bone, not cartilage — but the constituents were identified rather than assumed.
Then the arithmetic
A carcass survey measured how much chondroitin a broiler chicken actually contains. The answer: about 1.9 g in the entire 1.66 kg bird. Keel cartilage, the part usually named as the good source, held under 10 percent of it; most is distributed through the limb bones and joints.
The trial dose of chondroitin is 800–1200 mg per day. So a whole chicken contains one to two days' worth — if you extracted all of it, which cooking does not. The one measurement of transfer into soup reports a 0.14 percent process yield.
There is no plausible reading in which a bowl of stock delivers a studied chondroitin dose.
What the chondroitin dose actually buys
Worth knowing before chasing it. The Cochrane review pooled 43 trials and just over 9,000 participants. Its highest-quality result — high level of evidence, low risk of bias — is that 53 of 100 people on chondroitin achieved a 20 percent pain reduction against 47 of 100 on placebo. An absolute difference of six percentage points.
Joint space width loss was 4.7 percent less than placebo, also high quality. Serious adverse events were lower than placebo.
That is a real, replicated, small effect at a pharmaceutical dose. The reviewers add the sentence that matters most: benefits "were uncertain when we limited data to studies with appropriate allocation concealment, or large samples, or studies without pharmaceutical funding."
Hyaluronic acid: present, and fragile
Hyaluronan was the co-constituent in the active bone-broth fraction, so it is demonstrably in there. Two problems follow.
It is heat-labile — hyaluronic acid depolymerises readily in hot water, and long simmering should be expected to fragment it substantially. Nobody has measured how much survives.
And for chicken feet specifically, the only published hyaluronic acid figure comes from a paper that has since been retracted. This guide does not cite it, and the honest position is that the hyaluronic acid content of chicken feet is unknown.
Keratan and dermatan sulfate: nobody has looked
Keratan sulfate is a major glycosaminoglycan of aggrecan — it is genuinely part of the cartilage people are trying to eat. Dermatan sulfate decorates decorin and biglycan in tendon and skin.
Neither has ever been measured in any broth or stock. Not measured and found low — never looked for. There is likewise no oral keratan sulfate trial in any species, and no oral dermatan sulfate trial with a joint endpoint.
This distinction is load-bearing and this guide will keep making it: unmeasured is not the same as absent. Everything written anywhere about "the full spectrum of glycosaminoglycans in bone broth" is extrapolation from chondroitin.
The glucosamine mistake
One correction worth making explicitly, because the claim is everywhere and it is wrong at the first step.
Chondroitin sulfate contains no glucosamine. Its repeating disaccharide is glucuronic acid plus N-acetyl-galactosamine. Glucosamine occurs in hyaluronan, keratan sulfate and heparan sulfate — not chondroitin. So "long simmering breaks chondroitin down and releases glucosamine" is not a dosing question, it is a chemistry error.
Separately, liberating free glucosamine from the glycosaminoglycans that do contain it requires strong acid at length — the industrial process uses molar hydrochloric acid near boiling for hours. A tablespoon of vinegar in a stockpot is two to three orders of magnitude away, and a weak acid rather than a strong one.
There is no measurement of free glucosamine in bone stock, chicken feet, or any cooked food. Not low — unmeasured, and mechanistically implausible.
Why this tier? In-vitro extraction chemistry plus one animal study with a bone rather than cartilage endpoint. The chondroitin trial base is real and human, but it tested pharmaceutical-grade material at standardized doses and cannot be transferred to a food — a point the Cochrane review makes indirectly when it notes benefits become uncertain once you restrict to well-concealed, larger, or non-industry-funded trials. Nothing here establishes that glycosaminoglycans eaten in food reach or help a joint.
Key studies
- Chicken leg bone as a source of chondroitin sulfate
In vitro · 2019
PreclinicalChondroitin sulfate was recovered from ordinary chicken bone soup at a 0.14% yield. Crucially for anyone cooking stock, the soup-derived chondroitin averaged 35.81 kDa against 37.18 kDa for the enzymatic reference, with no significant structural difference on FTIR or HPLC — the molecule survives culinary cooking essentially intact.
- Hyaluronan and chondroitin sulfate in chicken-vegetable bone broth delay osteoporosis progression
Animal · 2024
PreclinicalThe broth fraction containing both hyaluronan and chondroitin sulfate maximally inhibited osteoclast differentiation and downregulated its marker genes; both whole broth and that fraction raised bone mineral density and bone volume/tissue volume on micro-CT versus ovariectomized controls. The first study to identify specific glycosaminoglycans in bone stock as the active constituents.
- Chondroitin for osteoarthritis
Systematic review · 2015 · n=9,110
PromisingThe most trustworthy numbers in the chondroitin literature, and they are small. On the highest-quality node — WOMAC minimal clinically important improvement, level of evidence HIGH, risk of bias LOW — 53 of 100 on chondroitin achieved a 20% pain reduction against 47 of 100 on placebo, an absolute difference of 6%. Loss of minimum joint space width was 4.7% less than placebo (also HIGH quality, LOW risk of bias). Short-term pain showed a 10% absolute risk difference but with I-squared of 70% and low-quality evidence. Serious adverse events were lower than placebo.